Do you know a conference you think we should list? Let us know by sending us an email with the details to [email protected].

In addition, Eisai must conduct a post-authorization safety study, including setting up a patient registry for the European Union. Now each European country must set its own rules for access and ...

A biobank with fresh and formalin-fixed specimens specializing in neurogenerative disease research.

As lecanemab gains regulatory approval in more countries (see previous story), clinicians are eager to learn from the first centers to have incorporated this therapeutic antibody into their clinical ...

B.A., English, University of Florida M.B.A., American Jewish University Ed.D., Organization of Leadership and Gerontology, Nova Southeastersn University ...

Talk about a closely watched study. Conference after conference, Roche scientists running the ongoing Brain Shuttle AD trial of trontinemab are dispensing morsels of news from sequential interim ...

Member reports the following financial or other potential conflicts of interest: E. Solje has served on the advisory board of Novartis, EISAI, Lilly and Roche, served as a consult for Novo Nordisk, ...

The blood-brain barrier border protects the brain by regulating the flow of molecules, peptides, and cells, but it also keeps ...